METLIFE INC (MET)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 17,340 | 18,569 | 18,440 | 17,823 |
| Policyholder dividends | 146 | 144 | 150 | 148 |
| Policyholder benefits and claims | 10,767 | 11,806 | 10,597 | 11,485 |
| Other expenses | 3,319 | 3,350 | 3,263 | 3,180 |
| Market risk benefit remeasurement (gains) losses | 277 | -299 | -531 | 182 |
| Policyholder liability remeasurement (gains) losses | -5 | 31 | 132 | 10 |
| Interest credited to policyholder account balances | 2,400 | 1,647 | 2,037 | 2,000 |
| Total expenses | 16,360 | 17,215 | 16,446 | 16,621 |
| Income (loss) before provision for income tax | 980 | 1,354 | 1,994 | 1,202 |
| Provision for income tax expense (benefit) | 245 | 404 | 653 | 249 |
| Net income (loss) | 735 | 950 | 1,341 | 953 |
| Less net income (loss) attributable to noncontrolling interests | 6 | 5 | -1 | 7 |
| Net income (loss) attributable to metlife, inc | 729 | 945 | 1,342 | 946 |
| Dividends, preferred stock | 31 | 66 | 67 | 34 |
| Net income (loss) available to metlife, inc.s common shareholders | 698 | 879 | 1,275 | 912 |
| Basic | 1.04 | 1.29 | 1.82 | 1.28 |
| Diluted | 1.03 | 1.28 | 1.81 | 1.28 |
| Weighted average common stock outstanding - basic | 670,800,000 | 682,300,000 | 699,300,000 | 710,500,000 |
| Weighted average common stock outstanding - diluted | 675,000,000 | 687,000,000 | 703,700,000 | 714,700,000 |